American National Bank & Trust (Virginia)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$832K Buy
16,507
+4,401
+36% +$224K 0.4% 70
2015
Q3
$582K Sell
12,106
-137
-1% -$7.13K 0.3% 88
2015
Q2
$637K Buy
12,243
+21
+0.2% +$1.18K 0.3% 88
2015
Q1
$705K Buy
12,222
+4,623
+61% +$265K 0.33% 83
2014
Q4
$406K Buy
+7,599
New +$425K 0.19% 109

Other funds holding GSK

American National Bank & Trust (Virginia)'s GSK Position: Q4 2015 in Review

American National Bank & Trust (Virginia) increased its GSK (GSK) stake by 36% in Q4 2015, buying an estimated $224K and bringing the position to 16,507 shares worth $832K. The position accounts for 0.4% of the portfolio, ranked #70.

American National Bank & Trust (Virginia) first reported a position in GSK in Q4 2014 and has held it in 5 quarters since. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • American National Bank & Trust (Virginia) held 16,507 shares of GSK worth $832K as of Q4 2015.
  • American National Bank & Trust (Virginia) bought 4,401 GSK shares in Q4 2015, an estimated $224K.
  • GSK made up 0.4% of American National Bank & Trust (Virginia)'s portfolio in Q4 2015, its #70 holding.
  • American National Bank & Trust (Virginia) first reported a position in GSK in Q4 2014 and has held it in 5 quarters since.
  • 719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q4 2015, filed 9 Feb 2016.